Work

Abstract 5336: A RAS(ON) multi-selective inhibitor combination therapy triggers long-term tumor control through senescence-associated tumor-immune equilibrium in preclinical models of PDAC

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5336

Authors: Caroline Broderick, Riccardo Mezzadra, Exequiel Sisso, Almudena Chaves-Perez, Ho Yu-Ji, Andrea Schietinger, Mallika Singh, Scott W. Lowe

Institutions: Memorial Sloan Kettering Cancer Center, Revolution Medicines (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409631387

Cites:

Cited by:

Related to: 10